Literature DB >> 23498985

Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI.

Vania Tacher1, MingDe Lin, Michael Chao, Lars Gjesteby, Nikhil Bhagat, Abdelkader Mahammedi, Roberto Ardon, Benoit Mory, Jean-François Geschwind.   

Abstract

RATIONALE AND
OBJECTIVES: To evaluate the precision and reproducibility of a semiautomatic tumor segmentation software in measuring tumor volume of hepatocellular carcinoma (HCC) before the first transarterial chemo-embolization (TACE) on contrast-enhancement magnetic resonance imaging (CE-MRI) and intraprocedural dual-phase C-arm cone beam computed tomography (DP-CBCT) images.
MATERIALS AND METHODS: Nineteen HCCs were targeted in 19 patients (one per patient) who underwent baseline diagnostic CE-MRI and an intraprocedural DP-CBCT. The images were obtained from CE-MRI (arterial phase of an intravenous contrast medium injection) and DP-CBCT (delayed phase of an intra-arterial contrast medium injection) before the actual embolization. Three readers measured tumor volumes using a semiautomatic three-dimensional volumetric segmentation software that used a region-growing method employing non-Euclidean radial basis functions. Segmentation time and spatial position were recorded. The tumor volume measurements between image sets were compared using linear regression and Student's t-test, and evaluated with intraclass-correlation analysis (ICC). The inter-rater Dice similarity coefficient (DSC) assessed the segmentation spatial localization.
RESULTS: All 19 HCCs were analyzed. On CE-MRI and DP-CBCT examinations, respectively, 1) the mean segmented tumor volumes were 87 ± 8 cm(3) (2-873) and 92 ± 10 cm(3) (1-954), with no statistical difference of segmented volumes by readers of each tumor between the two imaging modalities and the mean time required for segmentation was 66 ± 45 seconds (21-173) and 85 ± 34 seconds (17-214) (P = .19); 2) the ICCs were 0.99 and 0.974, showing a strong correlation among readers; and 3) the inter-rater DSCs showed a good to excellent inter-user agreement on the spatial localization of the tumor segmentation (0.70 ± 0.07 and 0.74 ± 0.05, P = .07).
CONCLUSION: This study shows a strong correlation, a high precision, and excellent reproducibility of semiautomatic tumor segmentation software in measuring tumor volume on CE-MRI and DP-CBCT images. The use of the segmentation software on DP-CBCT and CE-MRI can be a valuable and highly accurate tool to measure the volume of hepatic tumors.
Copyright © 2013 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23498985      PMCID: PMC3602801          DOI: 10.1016/j.acra.2012.11.009

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  24 in total

Review 1.  Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures.

Authors:  H K Lim; J K Han
Journal:  Abdom Imaging       Date:  2002 Mar-Apr

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

3.  Triple arterial phase dynamic MRI with sensitivity encoding for hypervascular hepatocellular carcinoma: comparison of the diagnostic accuracy among the early, middle, late, and whole triple arterial phase imaging.

Authors:  Kensaku Mori; Hiroshi Yoshioka; Nobuyuki Takahashi; Masayuki Yamaguchi; Teruko Ueno; Toshihiro Yamaki; Yukihisa Saida
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

4.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

5.  The impact of 2D versus 3D quantitation of tumor bulk determination on current methods of assessing response to treatment.

Authors:  K D Hopper; C J Kasales; K D Eggli; T R TenHave; N M Belman; P S Potok; M A Van Slyke; G J Olt; P Close; A Lipton; H A Harvey; J S Hartzel
Journal:  J Comput Assist Tomogr       Date:  1996 Nov-Dec       Impact factor: 1.826

6.  CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations.

Authors:  Srinivasa R Prasad; Kartik S Jhaveri; Sanjay Saini; Peter F Hahn; Elkan F Halpern; James E Sumner
Journal:  Radiology       Date:  2002-11       Impact factor: 11.105

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

9.  Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?

Authors:  Romaric Loffroy; MingDe Lin; Gayane Yenokyan; Pramod P Rao; Nikhil Bhagat; Niels Noordhoek; Alessandro Radaelli; Järl Blijd; Eleni Liapi; Jean-François Geschwind
Journal:  Radiology       Date:  2012-11-09       Impact factor: 11.105

10.  Statistical validation of image segmentation quality based on a spatial overlap index.

Authors:  Kelly H Zou; Simon K Warfield; Aditya Bharatha; Clare M C Tempany; Michael R Kaus; Steven J Haker; William M Wells; Ferenc A Jolesz; Ron Kikinis
Journal:  Acad Radiol       Date:  2004-02       Impact factor: 3.173

View more
  32 in total

1.  Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

Authors:  Yan Zhao; Rafael Duran; Wei Bai; Sonia Sahu; Wenjun Wang; Sven Kabus; MingDe Lin; Guohong Han; Jean-François Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2017-10-30       Impact factor: 2.740

2.  Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.

Authors:  Julius Chapiro; Laura D Wood; MingDe Lin; Rafael Duran; Toby Cornish; David Lesage; Vivek Charu; Rüdiger Schernthaner; Zhijun Wang; Vania Tacher; Lynn Jeanette Savic; Ihab R Kamel; Jean-François Geschwind
Journal:  Radiology       Date:  2014-07-15       Impact factor: 11.105

3.  Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.

Authors:  Zhijun Wang; Rongxin Chen; Rafael Duran; Yan Zhao; Gayane Yenokyan; Julius Chapiro; Rüdiger Schernthaner; Alessandro Radaelli; MingDe Lin; Jean-François Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2015-05-23       Impact factor: 2.740

4.  Automatic high-resolution infarct detection using volumetric multiphase dual-energy CT.

Authors:  Veit Sandfort; Alan C Kwan; Comfort Elumogo; Davis M Vigneault; Rolf Symons; Amir Pourmorteza; Kelly Rice; Cynthia Davies-Venn; Mark A Ahlman; Chia-Ying Liu; Stefan L Zimmerman; David A Bluemke
Journal:  J Cardiovasc Comput Tomogr       Date:  2017-04-18

5.  Three-Dimensional Quantitative Assessment of Uterine Fibroid Response after Uterine Artery Embolization Using Contrast-Enhanced MR Imaging.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; John D Werner; Zhijun Wang; Rüdiger Schernthaner; Lynn Jeanette Savic; Mark L Lessne; Jean-François Geschwind; Kelvin Hong
Journal:  J Vasc Interv Radiol       Date:  2015-01-28       Impact factor: 3.464

6.  Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; Rüdiger Schernthaner; David Lesage; Zhijun Wang; Lynn Jeanette Savic; Jean-François Geschwind
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

7.  Dual-phase cone-beam computed tomography to see, reach, and treat hepatocellular carcinoma during drug-eluting beads transarterial chemo-embolization.

Authors:  Vania Tacher; Mingde Lin; Nikhil Bhagat; Nadine Abi Jaoudeh; Alessandro Radaelli; Niels Noordhoek; Bart Carelsen; Bradford J Wood; Jean-François Geschwind
Journal:  J Vis Exp       Date:  2013-12-02       Impact factor: 1.355

8.  Quantitative tumor segmentation for evaluation of extent of glioblastoma resection to facilitate multisite clinical trials.

Authors:  James S Cordova; Eduard Schreibmann; Costas G Hadjipanayis; Ying Guo; Hui-Kuo G Shu; Hyunsuk Shim; Chad A Holder
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

9.  Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.

Authors:  Rongxin Chen; Jean-François Geschwind; Zhijun Wang; Vania Tacher; MingDe Lin
Journal:  J Vasc Interv Radiol       Date:  2013-10-01       Impact factor: 3.464

10.  Liver tissue classification in patients with hepatocellular carcinoma by fusing structured and rotationally invariant context representation.

Authors:  John Treilhard; Susanne Smolka; Lawrence Staib; Julius Chapiro; MingDe Lin; Georgy Shakirin; James Duncan
Journal:  Med Image Comput Comput Assist Interv       Date:  2017-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.